Microscopic Haematuria and Clinical Outcomes in Patients with Stage 3-5 Nondiabetic Chronic Kidney Disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  You Hsien Lin, Hugo ^a,b   Yen, Chun Yu ^a,d   Lim, Lee Moay ^a   Hwang, Daw Yang ^a   Tsai, Jer Chia ^a,b   Hwang, Shang Jyh ^a,b,c   Hung, Chi Chih ^a   Chen, Hung Chun ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROTEIN;

AGED; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; CYTOLOGY; DISEASE COURSE; ERYTHROCYTE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; URINALYSIS; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CREATININE; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMATURIA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEINS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URINALYSIS;

EID: 84944225429     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15242     Document Type: Article

References (39)

1. James, M. T., Hemmelgarn, B. R., Tonelli, M. Early recognition and prevention of chronic kidney disease. Lancet 375, 1296-1309, doi: 10.1016/s0140-6736(09)62004-3 (2010).
2. Jha, V., Wang, A. Y., Wang, H. The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant 27 Suppl 3, iii32-38, doi: 10.1093/ndt/gfs113 (2012).
3. Iseki, K. The okinawa screening program. J Am Soc Nephrol 14, S127-130 (2003).
4. Vivante, A. et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 306, 729-736, doi: 10.1001/jama.2011.1141 (2011).
5. Gutierrez, E. et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. Journal of the American Society of Nephrology: JASN 23, 1753-1760, doi: 10.1681/asn.2012010063 (2012).
6. Shen, P. et al. Clinicopathological characteristics and outcome of adult patients with hematuria and/or proteinuria found during routine examination. Nephron. Clinical practice 103, c149-156, doi: 10.1159/000092912 (2006).
7. Le, W. et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association-European Renal Association 27, 1479-1485, doi: 10.1093/ndt/gfr527 (2012).
8. Geetha, D., Seo, P., Ellis, C., Kuperman, M., Levine, S. M. Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy. J Rheumatol 39, 1413-1417, doi: 10.3899/jrheum.111608 (2012).
9. Beukhof, J. R. et al. Toward individual prognosis of IgA nephropathy. Kidney international 29, 549-556 (1986).
10. Goto, M. et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 24, 3068-3074, doi: 10.1093/ndt/gfp273 (2009).
11. Rauta, V. et al. Factors associated with progression of IgA nephropathy are related to renal function-a model for estimating risk of progression in mild disease. Clin Nephrol 58, 85-94 (2002).
12. Miura, N. et al. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 13, 460-466, doi: 10.1007/s10157-009-0179-1 (2009).
13. Moriyama, T. et al. Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol 44, 1177-1184, doi: 10.1007/s11255-011-0109-5 (2012).
14. Shimizu, A., Takei, T., Uchida, K., Tsuchiya, K., Nitta, K. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy. Nephrology (Carlton) 14, 521-526, doi: 10.1111/j.1440-1797.2009.01104.x (2009).
15. Hao, X. et al. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis. Contrib Nephrol 181, 101-108, doi: 10.1159/000348462 (2013).
16. Abrantes, M. M. et al. Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21, 1003-1012, doi: 10.1007/s00467-006-0138-y (2006).
17. Moreno, J. A. et al. Haematuria: the forgotten CKD factor? Nephrol Dial Transplant 27, 28-34, doi: 10.1093/ndt/gfr749 (2012).
18. Tracz, M. J., Alam, J., Nath, K. A. Physiology and pathophysiology of heme: implications for kidney disease. Journal of the American Society of Nephrology : JASN 18, 414-420, doi: 10.1681/ASN.2006080894 (2007).
19. Liu, W. C. et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 7, 541-548, doi: 10.2215/cjn.09420911 (2012).
20. Jalalah, S. M., Alzahrani, I. H., Furness, P. N. Glomerular changes in microscopic haematuria, studied by quantitative immunoelectron microscopy and in situ zymography. Nephrol Dial Transplant 17, 1586-1593 (2002).
21. Haider, D. G. et al. Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis. Eur J Clin Invest 44, 578-586, doi: 10.1111/eci.12274 (2014).
22. Pierides, A. et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association-European Renal Association 24, 2721-2729, doi: 10.1093/ndt/gfp158 (2009).
23. Manno, C. et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. American journal of kidney diseases : the official journal of the National Kidney Foundation 49, 763-775, doi: 10.1053/j.ajkd.2007.03.013 (2007).
24. Shen, K., Yu, Y., Tang, Z., Liu, Z., Li, L. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term followup of 86 cases. Chinese medical journal 110, 502-507 (1997).
25. Shiiki, H. et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney international 65, 1400-1407, doi: 10.1111/j.1523-1755.2004.00518.x (2004).
26. Kirpekar, R., Yorgin, P. D., Tune, B. M., Kim, M. K., Sibley, R. K. Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylprednisolone therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation 39, 1143-1152, doi: 10.1053/ajkd.2002.33382 (2002).
27. Wang, X. C. et al. Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy. Experimental and therapeutic medicine 6, 1243-1246, doi: 10.3892/etm.2013.1306 (2013).
28. Nonaka, K. et al. Clinical and pathological evaluation of hypertensive emergency-related nephropathy. Internal medicine 52, 45-53 (2013).
29. Harvey, J. M. et al. Renal biopsy findings in hypertensive patients with proteinuria. Lancet 340, 1435-1436 (1992).
30. Shantsila, A., Lane, D. A., Beevers, D. G., Lip, G. Y. Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. J Hypertens 30, 974-979, doi: 10.1097/HJH.0b013e3283526e47 (2012).
31. Hsu, C. Y., Iribarren, C., McCulloch, C. E., Darbinian, J., Go, A. S. Risk factors for end-stage renal disease: 25-year follow-up. Archives of internal medicine 169, 342-350, doi: 10.1001/archinternmed.2008.605 (2009).
32. James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama 311, 507-520, doi: 10.1001/jama.2013.284427 (2014).
33. Okada, T. et al. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria. Nephrology (Carlton) 18, 563-568, doi: 10.1111/nep.12104 (2013).
34. Impellizzeri, D., Esposito, E., Attley, J., Cuzzocrea, S. Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD). Pharmacol Res 81, 91-102, doi: 10.1016/j.phrs.2014.02.007 (2014).
35. Jalal, D., Chonchol, M., Etgen, T., Sander, D. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease. J Nephrol 25, 719-725, doi: 10.5301/jn.5000047 (2012).
36. Tsai, Y. C. et al. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. PLoS One 7, e52775, doi: 10.1371/journal.pone.0052775 (2012).
37. Knoop, T. et al. Mortality in patients with IgA nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation 62, 883-890, doi: 10.1053/j.ajkd.2013.04.019 (2013).
38. Jeong, C. W., Lee, S., Byun, S. S., Lee, D. H., Lee, S. E. No increase in risk of microscopic hematuria with aspirin use by asymptomatic healthy people. JAMA internal medicine 173, 1145-1146, doi: 10.1001/jamainternmed.2013.567 (2013).
39. Kang, M. et al. Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population. International journal of urology : official journal of the Japanese Urological Association 22, 389-393, doi: 10.1111/iju.12697 (2015).